There’s a bifurcation in healthcare: the companies that are fighting COVID-19, and the companies that are not. Many of the stocks of the former have zoomed higher. But others have seen delays in their business, and COVID-19 has hurt these stocks. Some of these companies are real bargains now.
Three Fool.com contributors like pulmonary specialist Pulmonx (NASDAQ:LUNG), Vertex Pharmaceuticals (NASDAQ:VRTX), and Axsome Therapeutics (NASDAQ:AXSM). Read on to see why these three stocks might crush the market over the next few years.